Outsourcing giant Capita will cut up to 900 jobs to reduce costs and save £60m per year from 2024. The cuts will largely affect support functions and overhead roles. The move follows Capita posting a pre-tax loss of £67.9m in H1 2021, and a 40% fall in share price after costs from a Russian cyber attack.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
